These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3263206)
1. MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder. Hansson Y; Vargas-Cortes M; Paulie S; Perlmann P Cancer Immunol Immunother; 1988; 27(3):205-12. PubMed ID: 3263206 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures. Troye M; Vilien M; Pape GR; Perlmann P Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743 [TBL] [Abstract][Full Text] [Related]
3. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes. Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886 [TBL] [Abstract][Full Text] [Related]
4. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype. Patel SS; Thiele DL; Lipsky PE J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232 [TBL] [Abstract][Full Text] [Related]
6. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4. Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439 [TBL] [Abstract][Full Text] [Related]
7. T-cell clones that react against autologous human tumors. Mukherji B; Chakraborty NG; Sivanandham M Immunol Rev; 1990 Aug; 116():33-62. PubMed ID: 2146210 [TBL] [Abstract][Full Text] [Related]
8. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators. Moroz C; Madgar I; Twig S; Lindner A; Many M Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847 [TBL] [Abstract][Full Text] [Related]
9. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules. Rivas A; Koide J; Laus R; Engleman EG J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178 [TBL] [Abstract][Full Text] [Related]
10. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111 [TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder. Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503 [TBL] [Abstract][Full Text] [Related]
12. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements. Gervois N; Heuze F; Diez E; Jotereau F Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794 [TBL] [Abstract][Full Text] [Related]
13. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. Itoh K; Platsoucas CD; Balch CM J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Warren EH; Greenberg PD; Riddell SR Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709 [TBL] [Abstract][Full Text] [Related]
15. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary. Perlmann P; Troye M; Pape G; Blomgren H; Johansson B Urol Res; 1978; 6(4):207-9. PubMed ID: 741533 [TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521 [TBL] [Abstract][Full Text] [Related]
17. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen. Dick T; Staege MS; Reichmann G; Reske-Kunz AB J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844 [TBL] [Abstract][Full Text] [Related]
18. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck. Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988 [TBL] [Abstract][Full Text] [Related]
19. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570 [TBL] [Abstract][Full Text] [Related]
20. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]